AC Immune SA (ACIU)
2.925
+0.06
(+2.27%)
USD |
NASDAQ |
Aug 25, 14:04
AC Immune Total Liabilities (Quarterly) : 142.85M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.85M |
| March 31, 2026 | 131.77M |
| December 31, 2025 | 138.05M |
| September 30, 2025 | 137.20M |
| June 30, 2025 | 145.08M |
| March 31, 2025 | 131.43M |
| December 31, 2024 | 130.92M |
| September 30, 2024 | 135.24M |
| June 30, 2024 | 126.99M |
| March 31, 2024 | 25.09M |
| December 31, 2023 | 26.34M |
| September 30, 2023 | 18.94M |
| June 30, 2023 | 18.89M |
| March 31, 2023 | 17.75M |
| December 31, 2022 | 18.32M |
| September 30, 2022 | 15.75M |
| June 30, 2022 | 14.60M |
| March 31, 2022 | 23.24M |
| December 31, 2021 | 32.34M |
| September 30, 2021 | 25.92M |
| June 30, 2021 | 23.59M |
| March 31, 2021 | 21.83M |
| December 31, 2020 | 26.32M |
| Date | Value |
|---|---|
| September 30, 2020 | 25.43M |
| June 30, 2020 | 23.64M |
| March 31, 2020 | 23.39M |
| December 31, 2019 | 27.68M |
| September 30, 2019 | 23.03M |
| June 30, 2019 | 23.52M |
| March 31, 2019 | 71.33M |
| December 31, 2018 | 19.21M |
| September 30, 2018 | 17.15M |
| June 30, 2018 | 17.28M |
| March 31, 2018 | 14.81M |
| December 31, 2017 | 15.57M |
| September 30, 2017 | 13.20M |
| June 30, 2017 | 10.86M |
| March 31, 2017 | 11.53M |
| December 31, 2016 | 13.50M |
| September 30, 2016 | 14.93M |
| June 30, 2016 | 13.08M |
| March 31, 2016 | 9.258M |
| December 31, 2015 | 8.879M |
| September 30, 2015 | 7.151M |
| June 30, 2015 | 6.390M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 3.973B |
| CRISPR Therapeutics AG | 904.22M |
| Idorsia Ltd. | 2.055B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.45M |
| Shareholders Equity (Quarterly) | 43.60M |
| Debt to Equity Ratio | 0.1166 |
| Current Ratio | 0.9318 |
| Net Debt Paydown Yield | 0.07% |